SlimLine

|
  • 0

SlimLine

Tuesday, 13 August 2019 | Pioneer

MedGenome Labs has developed SPIT SEQ, the first whole genome sequencing based test that can provide a detailed analysis of every single mutation present in any tuberculosis bacteria causing drug resistance-directly from the sputum. This break-through will enable a doctor to quickly and accurately prescribe the most effective drug to a tuberculosis patient without a trial and error process, followed currently that takes a month.

India has the largest number of multi drug resistant (MDR-TB) TB cases. SPIT SEQ can be a boon for TB patients, clinicians and healthcare agencies to achieve India’s Sustainable Development Goal (SDG) of elimination TB by 2025. The test is based on whole genome sequencing of mycobacterium tuberculosis (MTB), the TB causing bacteria, to assess the mutations in bacteria’s genome and allows a clinician to determine which drugs will work for a patient.

Sunday Edition

From the Kehwa Khanas to the Socials

17 November 2019 | Excerpt | Agenda

The Mystic pillars that unveiled a great king

17 November 2019 | Somen Sengupta | Agenda

Guru Nanak’s guide to leading a virtuous life

17 November 2019 | Excerpt | Agenda

Champions of Earth

17 November 2019 | Shalini Saksena | Sunday Pioneer

Talktime | ‘A star abused me on sets’

17 November 2019 | MUSBA HASHMI | Sunday Pioneer

DIFFerent experience

17 November 2019 | Shalini Saksena | Sunday Pioneer